Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14


Ursodeoxycholic acid inhibits Ras mutations, wild-type Ras activation, and cyclooxygenase-2 expression in colon cancer.

Khare S, Cerda S, Wali RK, von Lintig FC, Tretiakova M, Joseph L, Stoiber D, Cohen G, Nimmagadda K, Hart J, Sitrin MD, Boss GR, Bissonnette M.

Cancer Res. 2003 Jul 1;63(13):3517-23.


Rap1 activity is elevated in malignant astrocytomas independent of tuberous sclerosis complex-2 gene expression.

Lau N, Uhlmann EJ, Von Lintig FC, Nagy A, Boss GR, Gutmann DH, Guha A.

Int J Oncol. 2003 Jan;22(1):195-200.


Rheb is in a high activation state and inhibits B-Raf kinase in mammalian cells.

Im E, von Lintig FC, Chen J, Zhuang S, Qui W, Chowdhury S, Worley PF, Boss GR, Pilz RB.

Oncogene. 2002 Sep 12;21(41):6356-65.


Haploid loss of Ki-ras delays mammary tumor progression in C3 (1)/SV40 Tag transgenic mice.

Liu ML, Shibata MA, Von Lintig FC, Wang W, Cassenaer S, Boss GR, Green JE.

Oncogene. 2001 Apr 12;20(16):2044-9.


Activation of the Rap1 guanine nucleotide exchange gene, CalDAG-GEF I, in BXH-2 murine myeloid leukemia.

Dupuy AJ, Morgan K, von Lintig FC, Shen H, Acar H, Hasz DE, Jenkins NA, Copeland NG, Boss GR, Largaespada DA.

J Biol Chem. 2001 Apr 13;276(15):11804-11. Epub 2001 Jan 22.


Ras activation in human breast cancer.

von Lintig FC, Dreilinger AD, Varki NM, Wallace AM, Casteel DE, Boss GR.

Breast Cancer Res Treat. 2000 Jul;62(1):51-62.


Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1.

Bissonnette M, Khare S, von Lintig FC, Wali RK, Nguyen L, Zhang Y, Hart J, Skarosi S, Varki N, Boss GR, Brasitus TA.

Cancer Res. 2000 Aug 15;60(16):4602-9.


Cell type-specific regulation of B-Raf kinase by cAMP and 14-3-3 proteins.

Qiu W, Zhuang S, von Lintig FC, Boss GR, Pilz RB.

J Biol Chem. 2000 Oct 13;275(41):31921-9.


Ras activation in normal white blood cells and childhood acute lymphoblastic leukemia.

von Lintig FC, Huvar I, Law P, Diccianni MB, Yu AL, Boss GR.

Clin Cancer Res. 2000 May;6(5):1804-10.


1,25-dihydroxyvitamin D3 but not TPA activates PLD in Caco-2 cells via pp60(c-src) and RhoA.

Khare S, Bissonnette M, Wali R, Skarosi S, Boss GR, von Lintig FC, Scaglione-Sewell B, Sitrin MD, Brasitus TA.

Am J Physiol. 1999 Apr;276(4 Pt 1):G1005-15.


Amplification of Ki-ras and elevation of MAP kinase activity during mammary tumor progression in C3(1)/SV40 Tag transgenic mice.

Liu ML, Von Lintig FC, Liyanage M, Shibata MA, Jorcyk CL, Ried T, Boss GR, Green JE.

Oncogene. 1998 Nov 5;17(18):2403-11.


Deficient post-translational processing of Rap 1A in variant HL-60 cells.

Scheele JS, Pilz RB, von Lintig FC, Boss GR.

Oncogene. 1998 Oct 29;17(17):2211-23.

Supplemental Content

Loading ...
Support Center